Kenneth Pienta Cue Biopharma, Inc. (CUE) insider trading activity

CUE Quotes by TradingView

Kenneth Pienta is Chief Medical Officer of Cue Biopharma, Inc.. Currently has a direct ownership of 2,000 shares of CUE, which is worth approximately $3,040. The most recent transaction as insider was on Mar 16, 2021, when has been sold 439 shares (Common Stock) at a price of $15.09 per share, resulting in proceeds of $6,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2K
0% 3M change
0% 12M change
Total Value Held $3,040

Kenneth Pienta Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2021
SELL
Open market or private sale
$6,625 $15.09 p/Share
439 Reduced 18.0%
2,000 Common Stock
Mar 16 2021
BUY
Exercise of conversion of derivative security
$2,195 $5.0 p/Share
439 Added 15.25%
2,439 Common Stock
Mar 15 2021
SELL
Open market or private sale
$196,300 $15.1 p/Share
13,000 Reduced 86.67%
2,000 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
$65,000 $5.0 p/Share
13,000 Added 46.43%
15,000 Common Stock
Feb 17 2021
SELL
Open market or private sale
$64,324 $15.05 p/Share
4,274 Reduced 68.12%
2,000 Common Stock
Feb 17 2021
BUY
Exercise of conversion of derivative security
$16,797 $3.93 p/Share
4,274 Added 40.52%
6,274 Common Stock
Feb 16 2021
SELL
Open market or private sale
$242,400 $15.15 p/Share
16,000 Reduced 88.89%
2,000 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$45,760 $2.86 p/Share
16,000 Added 47.06%
18,000 Common Stock
Jan 20 2021
BUY
Open market or private purchase
$40,990 $15.07 p/Share
2,720 Added 36.56%
4,720 Common Stock
KP

Kenneth Pienta

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on CUE

Follow Cue Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CUE shares.

Notify only if

Insider Trading

Get notified when an Cue Biopharma, Inc. insider buys or sells CUE shares.

Notify only if

News

Receive news related to Cue Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CUE